Softtech Engineers Stock Eyes Breakout Above 470 According to Choice Broking Plus500 Reports 11 Quarterly Revenue Growth Reaffirms FullYear Outlook Capital Tankers Reports Robust Q1 2026 Results in First Earnings Call PostIPO Fluid Plumbing Electrical Air Conditioning Expands Residential Air Conditioning Services in Central Coast and Newcastle Signos Leverages AI and Dexcom Partnership to Capitalize on GLP1 Weight Loss Trend UK Chancellor Rachel Reeves Seeks to Preserve Role Amid Potential Labour Leadership Change Origin Bancorp Inc OBK Q1 2026 Earnings EPS Misses Estimates on Margin Headwinds RAPP Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise MGEE Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance SKY Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction FEED Q1 2026 Earnings Reported EPS of 688 Stock Declines on Widening Losses MDV Q1 2026 Earnings Industrial REIT Reports Deep Earnings Miss as Losses Sharply Exceed Estimates MGR Preferreds Hold Steady Near Midpoint of Trading Range Array Digital Infrastructure AD Holds Steady Near Support as Consolidation Continues Symbotic Inc SYM Surges 6 as Momentum Builds Toward Key Resistance Jade Biosciences Inc JBIO Slips 225 as Stock Nears Support Zone JewettCameron Trading JCTC Gains Ground Testing Key Resistance at 224 Milwaukee Brewers Top Prospect Jesus Made Could Bolster Franchise Value and Competitive Position Atmos Energy Corporation ATO Q1 2026 Earnings EPS Surpasses Estimates Stock Inches Higher Aberdeen India Fund IFN Holds Steady Near Resistance Amid Modest Uptick PFSI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment Edgewise Therapeutics Inc EWTX Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined RD execution VKTX Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues RD Investment ETSY Q1 2026 Earnings EPS Surges Past Estimates on 409 Beat QNRX Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment HDSN Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Reacts Negatively Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage